A Quick Look at Today's Ratings for LeMaitre Vascular(LMAT.US), With a Forecast Between $92 to $115
LeMaitre Vascular First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags
LeMaitre Vascular's Earnings Call Highlights Growth
LeMaitre Vascular To Go Ex-Dividend On May 15th, 2025 With 0.2 USD Dividend Per Share
Why LeMaitre (LMAT) Shares Are Sliding Today
LeMaitre Vascular Down Over 11%, on Track for Largest Percent Decrease Since October 2023 -- Data Talk
LeMatire Vascular Shares Are Trading Lower After the Company Reported Q1 EPS Guidance Below Estimates and Lowered Its FY25 EPS Guidance.
Lemaitre Vascular: Solid Revenue Growth Amid EPS and Margin Concerns Justifies Hold Rating
Lemaitre Vascular (LMAT) Gets a Buy From Stifel Nicolaus
KeyBanc Maintains LeMaitre Vascular(LMAT.US) With Hold Rating
LeMaitre Vascular Reports Strong Q1 2025 Growth
Earnings Call Summary | LeMaitre Vascular(LMAT.US) Q1 2025 Earnings Conference
LeMaitre's (NASDAQ:LMAT) Q1: Beats On Revenue, Guides for Strong Full-Year Sales
LeMaitre Vascular Declares $0.20 Dividend
Express News | LeMaitre Vascular Outlook FY25 EPS $2.07 - $2.24
Express News | LeMatire Vascular Shares Are Trading Lower After the Company Reported Q1 EPS Guidance Below Estimates and Lowered Its FY25 EPS Guidance
LEMAITRE VASCULAR Earnings Results: $LMAT Reports Quarterly Earnings
Express News | LeMaitre Vascular Sees Q2 GAAP EPS $0.55-$0.59 Vs $0.58 Est; Sees Sales $61.500M-$63.500M Vs $60.87M Est
GUIDANCE: (LMAT) Lemaitre Vascular Sees Fiscal Year 2025 Revenue $242M - $249M
Earnings Flash (LMAT) Lemaitre Vascular Posts Q1 Revenue $59.9M, Vs. FactSet Est of $57.6M